NCT06488378
- Conditions
- BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
PALB2-Mutated Breast Carcinoma
Explore clinical trials studying PALB2-Mutated Breast Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study